Integration of conventional medicine with holistic medicine: personalized approach, integrative concept

Authors

  • Ion MEREUȚĂ Nicolae Testemitanu State University of Medicine and Pharmacy; Academic Medical Center “Reviva Med”
  • Vladimir CARAUSH Academic Medical Center “Reviva Med”

DOI:

https://doi.org/10.52692/1857-0011.2025.2-82.49

Keywords:

concept, conventional medicine, holistic medicine, integrative medicine, personalized medicine

Abstract

In recent decades, conventional medicine has made remarkable advances in the diagnosis and treatment of acute and chronic diseases. However, a significant number of patients continue to experience residual symptoms, poor quality of life, or adverse reactions to standardized therapies. In this context, there is a growing trend toward integrating classical medicine with scientifically validated complementary approaches, within a patient-centered model tailored to individual biotypes. This article explores the scientific rationale for such integration, outlines the principles of personalized intervention, and illustrates its applicability through a documented clinical case of an oncology patient undergoing adjuvant therapy. Comparative tables of biological parameters and quality-of-life assessments are included, alongside a critical discussion of the limits and prospects of integrative medicine.

Author Biographies

Ion MEREUȚĂ , Nicolae Testemitanu State University of Medicine and Pharmacy; Academic Medical Center “Reviva Med”

Habilitated Doctor of Medical Sciences, University Professor, Corresponding Member of the Academy of Sciences of Moldova, Department of Oncology

Vladimir CARAUSH, Academic Medical Center “Reviva Med”

Doctor of Biological Sciences, R&D Director

References

Hunter DJ, Reddy KS. Noncommunicable diseases. In: N Engl J Med. 2013, 369(14), p. 1336-1343.

Block KI, Gyllenhaal C. Integrative therapies in cancer: Modulation of the tumor microenvironment. In: Integr Cancer Ther. 2015, 14(3) p. 228-240.

Seely D, Singh R, et al. A systematic review of integrative oncology programs. In: Curr Oncol. 2012, 19(3), p. e208-e222.

Leroy EC, Routhier F. The Systems Biology Revolution. In: Nature Rev Mol Cell Biol. 2018, 19(6), p. 400-414.

Witt CM et al. Integrative medicine in oncology: evidence, challenges and future directions. In: Nature Rev Clin Oncol. 2017, 14, p. 536-548.

Esposito K, et al. Anti-inflammatory effects of Mediterranean diet: the experience of the PREDIMED study. In: Proc Nutr Soc. 2010, 69(3), p. 331-336.

Kharat M, Du Z. Curcumin and health: a review. In: Crit Rev Food Sci Nutr. 2020, 60(2), p. 172-180.

Ulbricht C, et al. An evidence-based systematic review of boswellia. In: J Diet Suppl. 2008, 5(2), p. 193-208.

Yan J, et al. Intravenous high-dose vitamin C for cancer therapy: a systematic review. In: Nutrients. 2022, 14(2), p. 350.

Forman HJ, Zhang H. Targeting oxidative stress in disease. In: Nat Rev Drug Discov. 2021, 20(9), p. 689- 709.

Horneber M, et al. Complementary therapies in cancer: what is evidence-based? In: CA Cancer J Clin. 2012, 62(3), p. 170-193.

Ben-Arye E, et al. Complementary medicine in the supportive care of oncology patients. In: J Natl Cancer Inst Monogr. 2017, 52, p. 85-91.

Deng G, et al. Integrative medicine therapies in patients with head and neck cancer. In: J Soc Integr Oncol. 2008, 6(3), p. 102-109.

Dobos GJ, et al. Integrative oncology in Europe. In: J Tradit Chin Med Sci. 2021;8(3), p. 203-210.

Memorial Sloan Kettering Cancer Center – Integrative Medicine Service. [mskcc.org]

Bao T, et al. Complementary and alternative medicine in oncology. In: J Natl Cancer Inst Monogr. 2020, 2020(55), p. 54-61.

Ben-Arye E, et al. Integration of complementary medicine into supportive cancer care. In: Eur J Integr Med. 2013, 5(1), p. 58-62.

Kalapatapu VR, et al. Glutathione in chemotherapy - induced neuropathy. In: J Oncol Pharm Pract. 2022, 28(1), p. 56-63.

Cicero AFG, et al. Berberine and metabolic syndrome. In: Nutrients. 2021, 13(9). p. 2933.

Sharma P, et al. Traditional antidiabetic plants. In: J Ethnopharmacol. 2020, 261, p. 113157.

Smith M, et al. Natural supplements in aging males. In: Aging Male. 2018, 21(3), p. 161-168.

Furman D, et al. Chronic inflammation in the etiology of disease. In: Nat Med. 2019, 25(12), p. 1822-1832.

Zhang Y, et al. Epigenetic regulation of immune genes. In: Front Immunol. 2021, 12, p. 632772.

Spelman K, et al. Modulation of cytokines by phytotherapeutic agents. In: J Ethnopharmacol. 2006, 109(2), p. 199-205.

Hood L, Friend SH. P4 cancer medicine. In: Nat Rev Clin Oncol. 2011, 8(3), p. 184-187.

López-Lázaro M. Luteolin distribution and biological activity. In: Mini Rev Med Chem. 2009, 9(1), p. 31-59.

Horwitz RI, et al. From evidence-based to medicine- based evidence. In: Am J Med. 2017, 130(11), p. 1246- 1250.

Jameson JL, Longo DL. Precision medicine. In: N Engl J Med. 2015, 372, p. 2229-2234.

Epstein RM, Street RL. Patient-centered care. In: Ann Fam Med. 2011, 9(2), p. 100-103.

Laidlaw TM, et al. Inflammation in chronic disease. In: J Intern Med. 2021, 289(5), p. 560-578.

De Mello VD, et al. Diet and inflammation. In: Curr Opin Clin Nutr Metab Care. 2019, 22(5), p. 385-392.

Aggarwal BB, et al. Curcumin: the Indian solid gold. In: Adv Exp Med Biol. 2007, 595, p. 1-75.

Ulbricht C, Basch E. Ganoderma lucidum review. In: J Diet Suppl. 2010, 7(4), p. 365-439.

Mikirova N, et al. IV vitamin C in cancer. In: J Transl Med. 2013, 11, p. 191.

Foster JA, et al. Microbiome and anxiety. In: Trends Neurosci. 2013, 36(5), p. 305-312.

Pizzorno J. Detoxification strategies. In: Integr Med (Encinitas). 2015, 14(1), p. 8-16.

Published

2026-03-26

Issue

Section

Research Article

Categories